233 related articles for article (PubMed ID: 35500744)
1. Impact of COVID19 pandemic on the incidence of health-care associated Clostridioides difficile infection.
Merchante N; Chico P; Márquez-Saavedra E; Riera G; Herrero R; González-de-la-Aleja P; Aller AI; Rodríguez JC; Rodríguez-Fernández M; Ramos JM; Trigo-Rodríguez M; Merino E
Anaerobe; 2022 Jun; 75():102579. PubMed ID: 35500744
[TBL] [Abstract][Full Text] [Related]
2. Healthcare-associated
Manea E; Jipa R; Milea A; Roman A; Neagu G; Hristea A
Rom J Intern Med; 2021 Dec; 59(4):409-415. PubMed ID: 34053203
[No Abstract] [Full Text] [Related]
3. Increase of healthcare-onset Clostridioides difficile infection in adult population since SARS-CoV-2 pandemic: A retrospective cohort study in a tertiary care hospital from 2019 to 2022.
Maldonado-Barrueco A; Moreno-Ramos F; Díaz-Pollán B; Loeches-Yagüe B; Rico-Nieto A; García-Rodríguez J; Ruiz-Carrascoso G
Anaerobe; 2024 Apr; 86():102836. PubMed ID: 38428802
[TBL] [Abstract][Full Text] [Related]
4. Clostridioides difficile infection (CDI) during the COVID-19 pandemic.
Spigaglia P
Anaerobe; 2022 Apr; 74():102518. PubMed ID: 35063599
[TBL] [Abstract][Full Text] [Related]
5. Identification of antibiotic consumption targets for the management of
Aldeyab MA; Bond SE; Gould I; Lee-Milner J; Spencer-Jones JJ; Guleri A; Sadeq A; Jirjees F; Lattyak WJ
Expert Rev Anti Infect Ther; 2023; 21(10):1125-1134. PubMed ID: 37755320
[TBL] [Abstract][Full Text] [Related]
6. Implication of COVID-19 pandemic on the incidence of
Karampatakis T; Tsergouli K; Kandilioti E; Nikopoulou A; Katsifa H; Kachrimanidou M
J Med Microbiol; 2023 May; 72(5):. PubMed ID: 37195744
[No Abstract] [Full Text] [Related]
7. Impact of the coronavirus disease 2019 (COVID-19) pandemic on nosocomial
Ponce-Alonso M; Sáez de la Fuente J; Rincón-Carlavilla A; Moreno-Nunez P; Martínez-García L; Escudero-Sánchez R; Pintor R; García-Fernández S; Cobo J
Infect Control Hosp Epidemiol; 2021 Apr; 42(4):406-410. PubMed ID: 32895065
[TBL] [Abstract][Full Text] [Related]
8. Association between Antibiotic Consumption and Incidence of
Kim B; Kim J; Pai H
J Korean Med Sci; 2020 Dec; 35(47):e407. PubMed ID: 33289370
[TBL] [Abstract][Full Text] [Related]
9. Trends in facility-level rates of
Rose AN; Baggs J; Kazakova SV; Guh AY; Yi SH; McCarthy NL; Jernigan JA; Reddy SC
Infect Control Hosp Epidemiol; 2023 Feb; 44(2):238-245. PubMed ID: 35586888
[TBL] [Abstract][Full Text] [Related]
10. Did Clostridioides difficile testing and infection rates change during the COVID-19 pandemic?
Hawes AM; Desai A; Patel PK
Anaerobe; 2021 Aug; 70():102384. PubMed ID: 34029702
[TBL] [Abstract][Full Text] [Related]
11. Incidence, epidemiology and control of
Singhal T; Shah S; Tejam R; Thakkar P
Indian J Med Microbiol; 2018; 36(3):381-384. PubMed ID: 30429391
[TBL] [Abstract][Full Text] [Related]
12. Temporal change of risk factors in hospital-acquired
Song J; Cohen B; Zachariah P; Liu J; Larson EL
Infect Control Hosp Epidemiol; 2020 Sep; 41(9):1048-1057. PubMed ID: 32468975
[TBL] [Abstract][Full Text] [Related]
13. Burden of Clostridioides difficile infection (CDI) - a systematic review of the epidemiology of primary and recurrent CDI.
Finn E; Andersson FL; Madin-Warburton M
BMC Infect Dis; 2021 May; 21(1):456. PubMed ID: 34016040
[TBL] [Abstract][Full Text] [Related]
14. Association of ward-level antibiotic consumption with healthcare-associated Clostridioides difficile infections: an ecological study in five German university hospitals, 2017-2019.
Rohde AM; Mischnik A; Behnke M; Dinkelacker A; Eisenbeis S; Falgenhauer J; Gastmeier P; Häcker G; Herold S; Imirzalioglu C; Käding N; Kramme E; Peter S; Piepenbrock E; Rupp J; Schneider C; Schwab F; Seifert H; Steib-Bauert M; Tacconelli E; Trauth J; Vehreschild MJGT; Walker SV; Kern WV; Jazmati N;
J Antimicrob Chemother; 2023 Sep; 78(9):2274-2282. PubMed ID: 37527398
[TBL] [Abstract][Full Text] [Related]
15. Impact of Clostridioides difficile length of treatment on rates of recurrence in patients on concurrent antibiotics.
Rajakumar I; Jaber R; Ali R; Rennert-May E; Sabuda D
Am J Infect Control; 2023 Nov; 51(11):1213-1217. PubMed ID: 37105356
[TBL] [Abstract][Full Text] [Related]
16. Hospital-level high-risk antibiotic use in relation to hospital-associated
Tabak YP; Srinivasan A; Yu KC; Kurtz SG; Gupta V; Gelone S; Scoble PJ; McDonald LC
Infect Control Hosp Epidemiol; 2019 Nov; 40(11):1229-1235. PubMed ID: 31522695
[TBL] [Abstract][Full Text] [Related]
17. The Effect of Saccharomyces boulardii Primary Prevention on Risk of Hospital-onset Clostridioides difficile Infection in Hospitalized Patients Administered Antibiotics Frequently Associated With C. difficile Infection.
Wombwell E; Patterson ME; Bransteitter B; Gillen LR
Clin Infect Dis; 2021 Nov; 73(9):e2512-e2518. PubMed ID: 32575126
[TBL] [Abstract][Full Text] [Related]
18. Impact of COVID-19 pandemic on prevalence of Clostridioides difficile infection in a UK tertiary centre.
Voona S; Abdic H; Montgomery R; Clarkson A; Twitchell H; Hills T; Briggs S; Crooks C; Monaghan TM
Anaerobe; 2022 Feb; 73():102479. PubMed ID: 34801705
[TBL] [Abstract][Full Text] [Related]
19. Impact of COVID-19 prevention measures on risk of health care-associated Clostridium difficile infection.
Bentivegna E; Alessio G; Spuntarelli V; Luciani M; Santino I; Simmaco M; Martelletti P
Am J Infect Control; 2021 May; 49(5):640-642. PubMed ID: 33031863
[TBL] [Abstract][Full Text] [Related]
20. Epidemiology of Clostridioides difficile infection in hospitalized patients in Spain: An eight-year review (2012-2019).
Asensio Á; Vallejo-Plaza A; Parra LM; Ortí-Lucas R; Salcedo I; Ramos A; Cantero M;
Enferm Infecc Microbiol Clin (Engl Ed); 2022 Mar; 40(3):125-130. PubMed ID: 35249672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
